|
[1]FAN JG.Differences and similarities of guidelines from China and abroad on the diagnosis and management including liver transplantation of nonalcoholic fatty liver disease[J].J Clin Hepatol, 2012, 28 (7) :493-495. (in Chinese) 范建高.国内外非酒精性脂肪性肝病诊疗指南的异同[J].临床肝胆病杂志, 2012, 28 (7) :493-495.
|
|
[2]Joint Committee for developing Chinese Guidelines for the management of dyslipidemia in adults.Chinese guidelines for the management of dyslipidemia adults[J].Chin J Cardiol, 2007, 35 (5) :390-419. (in Chinese) 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志, 2007, 35 (5) :390-419.
|
|
[3]PAMILO M, SOTANIEMI EA, SURAMO I, et al.Evaulation of liver steatotic and fibrous content by computerized tomography and ultrasound[J].Scand J Gastroenterol, 1983, 18 (6) :743-747.
|
|
[4]DONG S, LIU P, SUN MY.Role of“two-hit”in non-alcoholic fatty liver disease[J].J Clin Hepatol, 2012, 28 (7) :551-555. (in Chinese) 董姝, 刘平, 孙明瑜.非酒精性脂肪肝发病机制——“二次打击”学说研究进展[J].临床肝胆病杂志, 2012, 28 (7) :551-555.
|
|
[5]FORBES S, TAYLOR-ROBINSON SD, PATEL N, et al.Increased prevalence of non-alcoholic fatty liver disease in European women with a history of gestational diabetes[J].Diabetologia, 2011, 54 (3) :641-647.
|
|
[6]RUHL CE, EVERHART JE.Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population[J].Am J Gastroenterol, 2013, 108 (6) :952-958.
|
|
[7]AMIGO L, HUSCHE C, ZANLUNGO S, et al.Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice[J].Liver Int, 2011, 31 (1) :52-64.
|
|
[8]KULLAK-UBLICK GA, PAUMGARTNER G, BERR F.Longterm effects of cholecystectomy on bile acid metabolism[J].Hepatology, 1995, 21 (1) :41-45.
|
|
[9]LEFEBVRE P, CARIOU B, LIEN F, et al.Role of bile acids and bile acid receptors in metabolic regulation[J].Physiol Rev, 2009, 89 (1) :147-191.
|
|
[10]TRAUNER M, CLAUDEL T, FICKERT P, et al.Bile acids as regulators of hepatic lipid and glucose metabolism[J].Dig Dis, 2010, 28 (1) :220-224.
|
|
[11]JONES S.Mini-review:endocrine actions of fibroblast growth factor19[J].Mol Pharm, 2008, 5 (1) :42-48.
|
|
[12]EREN F, KURT R, ERMIS F, et al.Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease[J].Clin Biochem, 2012, 45 (9) :655-658.
|
DownLoad: